Evidence map›Paper›PMID 35197055›Full record

ArticleBMC medical genomics2022

A novel prognostic model for hepatocellular carcinoma based on 5 microRNAs related to vascular invasion.

Wei Chen, Hao Wang, Tong Li, Te Liu, Wenjing Yang, Anli Jin, Lin Ding, Chunyan Zhang, Baishen Pan, Wei Guo and 1 more

Abstract read
In one paragraph

Article in BMC medical genomics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Wei Chen *Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Hao Wang *Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Tong Li *Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Te LiuDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Wenjing YangDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Anli JinDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Lin DingDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Chunyan ZhangDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Baishen PanDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Wei GuoDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. guo.wei@zs-hospital.sh.cn.
Beili WangDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. wang.beili1@zs-hospital.sh.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatocellular carcinoma (HCC) is prevalent worldwide with a high mortality rate. Prognosis prediction is crucial for improving HCC patient outcomes, but effective tools are still lacking. Characteristics related to vascular invasion (VI), an important process involved in HCC recurrence and metastasis, may provide ideas on prognosis prediction.

methodsTools, including R 4.0.3, Funrich version 3, Cytoscape 3.8.2, STRING 11.5, Venny 2.1.0, and GEPIA 2, were used to perform bioinformatic analyses. The VI-related microRNAs (miRNAs) were identified using Gene Expression Omnibus HCC miRNA dataset GSE67140, containing 81 samples of HCC with VI and 91 samples of HCC without VI. After further evaluated the identified miRNAs based on The Cancer Genome Atlas database, a prognostic model was constructed via Cox regression analysis. The miRNAs in this model were also verified in HCC patients. Moreover, a nomogram was developed by integrating risk score from the prognostic model with clinicopathological parameters. Finally, a potential miRNA-mRNA network related to VI was established through weighted gene co-expression network analysis of HCC mRNA dataset GSE20017, containing 40 samples of HCC with VI and 95 samples of HCC without VI.

resultsA prognostic model of 5 VI-related miRNAs (hsa-miR-126-3p, hsa-miR-148a-3p, hsa-miR-15a-5p, hsa-miR-30a-5p, hsa-miR-199a-5p) was constructed. The area under receiver operating characteristic curve was 0.709 in predicting 5-year survival rate, with a sensitivity of 0.74 and a specificity of 0.63. The nomogram containing risk score could also predict prognosis. Moreover, a VI-related miRNA-mRNA network covering 4 miRNAs and 15 mRNAs was established.

conclusionThe prognostic model and nomogram might be potential tools in HCC management, and the VI-related miRNA-mRNA network gave insights into how VI was developed.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsMicroRNAsBiomarkers, TumorGene Expression ProfilingHumansPrognosisRNA, MessengerBiomarkers, TumorMicroRNAsMIRN30a microRNA, humanRNA, MessengerCo-expression networkHepatocellular carcinomamicroRNAOverall survivalPrognostic modelVascular invasion

Identifiers

PMID35197055
PMCPMC8867887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.